Zini Laurent, Haulon Stephan, Leroy Xavier, Christophe Decoene, Koussa Mohamed, Biserte Jacques, Villers Arnauld
Department of Urology, Lille Regional University Teaching Hospital (CHRU), Lille, France.
BJU Int. 2006 Jun;97(6):1216-20. doi: 10.1111/j.1464-410X.2006.06168.x.
To evaluate endoluminal occlusion of the inferior vena cava (IVC) during surgical treatment of renal cell carcinoma (RCC) with either retrohepatic (level II) or suprahepatic (level III) caval tumour thrombus.
From January 2000 to February 2005, 31 patients with renal vein/IVC involvement (T3b/c) of 278 who had a radical nephrectomy, were selected for review. Of these 31, 13 consecutive patients with RCC presenting a thrombus level II or III were prospectively treated with endoluminal occlusion of the free IVC cranial to the thrombus, to avoid dissection of the suprahepatic IVC or the subdiaphragmatic IVC. The occlusion balloon was positioned using transoesophageal echocardiography (TEE) control through a cavotomy at the ostium of the renal vein. Thrombectomy and radical nephrectomy were then performed. The operative duration, peri-operative bleeding, and complications during and after surgery were assessed. Overall patient survival time, disease-free survival and development of metastasis were calculated.
Caval thrombectomy was successful in all patients. The IVC needed to be replaced with an expanded polytetrafluoroethylene graft in three patients and a patch closure after lateral cavectomy was used in four. There was no case of air embolism. One case of asymptomatic tumour migration was detected during the procedure by TEE. The mean (sd) and median (range) operative duration was 170 (29) and 170 (120-210) min, and the mean number of units of packed red cells transfused during hospitalization was 5 (5) and 3 (0-16). There was no peri-operative mortality. The complications were one splenectomy and one early thrombosis of the IVC. The mean (range) follow-up was 22.1 (2-50) months. Distant metastases occurred in seven patients; there was no local or IVC tumour recurrence. Four patients died from metastatic progression and six are alive with no progression.
Endoluminal occlusion of the IVC with TEE monitoring for level II and III thrombus avoided a suprahepatic or subdiaphragmatic approach to the IVC. This technique caused no major complications and was very reliable, due to TEE monitoring. Segmental resection and reconstruction of the IVC could also be used for adherent thrombi.
评估在手术治疗伴有肝后段(Ⅱ级)或肝上段(Ⅲ级)下腔静脉瘤栓的肾细胞癌时,下腔静脉腔内闭塞术的效果。
选取2000年1月至2005年2月期间接受根治性肾切除术的278例肾静脉/下腔静脉受累(T3b/c)患者中的31例进行回顾性研究。在这31例患者中,连续13例伴有Ⅱ级或Ⅲ级瘤栓的肾细胞癌患者接受了前瞻性治疗,即在瘤栓上方的游离下腔静脉进行腔内闭塞,以避免解剖肝上段下腔静脉或膈下下腔静脉。通过经食管超声心动图(TEE)控制,经肾静脉开口处的腔静脉切开术放置闭塞球囊。然后进行血栓切除术和根治性肾切除术。评估手术时长、围手术期出血情况以及手术期间和术后的并发症。计算患者的总体生存时间、无病生存期和转移情况。
所有患者的腔静脉血栓切除术均成功。3例患者需要用膨体聚四氟乙烯移植物替换下腔静脉,4例患者在侧壁腔静脉切除术后采用补片闭合。无空气栓塞病例。术中通过TEE检测到1例无症状肿瘤迁移。平均(标准差)和中位数(范围)手术时长分别为170(29)分钟和170(120 - 210)分钟,住院期间输注浓缩红细胞的平均单位数分别为5(5)单位和3(0 - 16)单位。无围手术期死亡。并发症包括1例脾切除术和1例下腔静脉早期血栓形成。平均(范围)随访时间为22.1(2 - 50)个月。7例患者发生远处转移;无局部或下腔静脉肿瘤复发。4例患者死于转移进展,6例患者存活且无疾病进展。
对于Ⅱ级和Ⅲ级瘤栓,采用TEE监测的下腔静脉腔内闭塞术避免了对肝上段或膈下下腔静脉的手术入路。由于TEE监测,该技术未引起重大并发症且非常可靠。对于粘连性血栓,也可采用下腔静脉节段性切除和重建术。